Isolation and Characterization of an RNA Aptamer for the HPV-16 E7 Oncoprotein

Archives of Medical Research

Volumn 42, Issue 2, 2011, Pages 88-96

  Toscano Garibay, Julia D ^a   Benítez Hess, María L ^a   Alvarez Salas, Luis M ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Aptamer; Cervical cancer; E7 protein; Oligonucleotide; Papillomavirus; RNA

Indexed keywords

APTAMER; PROTEIN E7;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MOLECULAR CLONING; NONHUMAN; PAPILLOMAVIRUS INFECTION; PROTEIN BINDING; PROTEIN FOOTPRINTING; SLOT BLOT HYBRIDIZATION; UTERINE CERVIX CARCINOMA;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CELL EXTRACTS; CELLS, CULTURED; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; NUCLEOTIDE MAPPING; PAPILLOMAVIRUS E7 PROTEINS; PROTEIN BINDING; SELEX APTAMER TECHNIQUE; UTERINE CERVICAL NEOPLASMS;

EID: 79955705522     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.02.005     Document Type: Article

References (30)

1. Stanley M.A., Pett M.R., Coleman N. HPV: from infection to cancer. Biochem Soc Trans 2007, 35:1456-1460.
2. Liu X., Clements A., Zhao K., et al. Structure of the human papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor. J Biol Chem 2006, 281:578-586.
3. Pirisi L., Yasumoto S., Feller M., et al. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol 1987, 61:1061-1066.
4. DiPaolo J.A., Popescu N.C., Alvarez L., et al. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. Crit Rev Oncog 1993, 4:337-360.
5. Duensing S., Münger K. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 2002, 62:7075-7082.
6. DiPaolo J.A., Alvarez-Salas L.M. Advances in the development of therapeutic nucleic acids against cervical cancer. Expert Opin Biol Ther 2004, 4:1251-1264.
7. Dyson N., Howley P.M., Münger K., et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989, 243:934-937.
8. Münger K., Basile J.R., Duensing S., et al. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 2001, 20:7888-7898.
9. McLaughlin-Drubin M.E., Münger K. Oncogenic activities of human papillomaviruses. Virus Res 2009, 143:195-208.
10. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510.
11. Ellington A.D., Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822.
12. Stoltenburg R., Reinemann C., Strehlitz B. SELEX-a (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng 2007, 24:381-403.
13. Mann D., Reinemann C., Stoltenburg R., et al. In vitro selection of DNA aptamers binding ethanolamine. Biochem Biophys Res Commun 2005, 338:1928-1934.
14. Alvarez-Salas L.M. Nucleic acids as therapeutic agents. Curr Top Med Chem 2008, 8:1379-1404.
15. Nimjee S.M., Rusconi C.P., Sullenger B.A. Aptamers: an emerging class of therapeutics. Annu Rev Med 2005, 56:555-583.
16. Márquez-Gutiérrez M.A., Benitez-Hess M.L., DiPaolo J.A., et al. Effect of combined antisense oligodeoxynucleotides directed against the human papillomavirus type 16 on cervical carcinoma cells. Arch Med Res 2007, 38:730-738.
17. Wong I., Lohman T.M. A double-filter method for nitrocellulose-filter binding: application to protein-nucleic acid interactions. Proc Natl Acad Sci USA 1993, 90:5428-5432.
18. Goodrich J.A., Kugel J.F. Binding and Kinetics for Molecular Biologists 2007, CSH Laboratory Press, Cold Spring Harbor, NY. 1st ed.
19. Oney S., Nimjee S.M., Layzer J., et al. Antidote-controlled platelet inhibition targeting von Willebrand factor with aptamers. Oligonucleotides 2007, 17:265-274.
20. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 2003, 31:3406-3415.
21. Liu X., Cao G., Ding H., et al. Screening of functional antidotes of RNA aptamers against bovine thrombin. FEBS Lett 2004, 562:125-128.
22. Li N., Wang Y., Pothukuchy A., et al. Aptamers that recognize drug-resistant HIV-1 reverse transcriptase. Nucleic Acids Res 2008, 36:6739-6751.
23. Kang J., Lee M.S., Watowich S.J., et al. Combinatorial selection of a RNA thioaptamer that binds to Venezuelan equine encephalitis virus capsid protein. FEBS Lett 2007, 581:2497-2502.
24. Gopinath S.C., Misono T.S., Kawasaki K., et al. An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion. J Gen Virol 2006, 87:479-487.
25. Bryant K.F., Cox J.C., Wang H., et al. Binding of herpes simplex virus-1 US11 to specific RNA sequences. Nucleic Acids Res 2005, 33:6090-6100.
26. Geiger A., Burgstaller P., von der E., et al. RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity. Nucleic Acids Res 1996, 24:1029-1036.
27. Liu M., Kagahara T., Abe H., et al. In vitro selection of RNA aptamer to hemin. Nucleic Acids Symp Ser (Oxf) 2008, 513-514.
28. Carothers J.M., Oestreich S.C., Davis J.H., et al. Informational complexity and functional activity of RNA structures. J Am Chem Soc 2004, 126:5130-5137.
29. Lozupone C., Changayil S., Majerfeld I., et al. Selection of the simplest RNA that binds isoleucine. RNA 2003, 9:1315-1322.
30. Marquis J., Paillard L., Audic Y., et al. CUG-BP1/CELF1 requires UGU-rich sequences for high-affinity binding. Biochem J 2006, 400:291-301.